Junko Homan

Efficacy of NS-018, a potent and selective JAK2/Src inhibitor, in primary cells and mouse models of myeloproliferative neoplasms

Yohei Nakaya, Kotaro Shide, T. Niwa et al. · Blood Cancer Journal · 2011 · 45 citations · Full text

Immunology, Janus Kinase 2, Cell Death +16

Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.

Sachie Kimura, Kazuya Kuramoto, Junko Homan et al. · PubMed · 2012 · 31 citations

A comparison of vasodilation mode among selexipag (NS-304; [2-{4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide]), its active metabolite MRE-269 and various prostacyclin receptor agonists in rat, porcine and human pulmonary arteries

Chiaki Fuchikami, Kohji Murakami, Koyuki Tajima et al. · European Journal of Pharmacology · 2016 · 18 citations

Medicinal Chemistry, Vasodilation Mode, Medicine +10